CAS |
No.1040526-12-2 |
英文名称 |
LP-533401 hydrochloride |
别名 |
LP-533401 HCl; |
分子式 |
C27H23ClF4N4O3 |
分子量 |
562.94 |
溶解性 |
Soluble in DMSO ≥3mg/mL(Need ultrasonic) |
纯度 |
≥98% |
外观(性状) |
Light yellow to yellow Solid |
储存条件 |
Powder:2-8℃,2 years;Insolvent(母液):-20℃,6 months;-80℃,1 year |
MDL |
MFCD18803629 |
SMILES |
C1=CC(=CC(=C1)F)C2=CC=C(C=C2)C(C(F)(F)F)OC3=NC(=NC(=C3)C4=CC=C(C=C4)C[C@@H](C(=O)O)N)N.Cl |
InChIKey |
BHBWZCUMIXCDPM-CHXZROHQSA-N |
InChI |
InChI=1S/C27H22F4N4O3.ClH/c28-20-3-1-2-19(13-20)16-8-10-18(11-9-16)24(27(29,30)31)38-23-14-22(34-26(33)35-23)17-6-4-15(5-7-17)12-21(32)25(36)37;/h1-11,13-14,21,24H,12,32H2,(H,36,37)(H2,33,34,35);1H/t21-,24 ;/m0./s1 |
PubChem CID |
102602704 |
靶点 |
Tryptophan Hydroxylase |
通路 |
Metabolic Enzyme&Protease |
背景说明 |
LP-533401 hydrochloride 是色氨酸羟化酶 1 (tryptophan hydroxylase 1) 抑制剂。 |
生物活性 |
LP-533401 hydrochloride is a tryptophan hydroxylase 1 inhibitor that regulates serotonin production in the gut.[1-3] |
In Vitro |
LP-533401 hydrochloride 是一种色氨酸羟化酶 1 抑制剂。处理 3 天后,LP-533401 (1 μM) 完全抑制表达 Tph1 的细胞 (RBL2H3 细胞) 中的血清素生成[1]。 |
In Vivo |
LP-533401 (25、100 或 250 mg/kg) 每天一次口服给药长达 6 周,剂量依赖性地预防并完全挽救切除卵巢的啮齿动物的骨质疏松症,因为骨形成单独增加。啮齿类动物的药代动力学研究表明,LP-533401 在口服给药后在大脑中的水平可以忽略不计,表明它几乎无法穿过血脑屏障[1]。用 LP-533401 (每天 30-250 mg/kg) 反复处理的小鼠在肠道、肺和血液中表现出显著的 5-HT 含量减少,但在大脑中没有。单剂量 LP-533401 (250 mg/kg) 后,肺和肠道 5-HT 含量降低 50%,而血液 5-HT 水平保持不变,表明肠道和肺 5-HT 合成[2]。用 Tph-1 抑制剂 LP-533401 处理的成年健康小鼠的循环血清素水平降低了 30%,随之而来的成骨细胞数量增加了 30%。对注射了 EL4 细胞的小鼠施用 LP-533401 可抑制成骨细胞数量和骨小梁体积的减少,延长生存期,并减少白血病浸润[3]。 |
动物实验 |
Mice[1]Mice are treated from day 1 post-ovariectomy for 4 weeks with LP-533401 (1, 10, 100 or 250 mg per kg body weight per day) or vehicle. Next mice are treated for 4 weeks starting 2 weeks post-ovariectomy with LP-533401 (250 mg per kg body weight per day) or vehicle. lastly, mice are treated for 6 weeks starting 6 weeks post-ovariectomy with LP-533401 (25, 100 or 250 mg per kg body weight per day) or vehicle[1]. |
数据来源文献 |
[1]. Yadav, V.K., et al. Inhibition of gut-derived serotonin synthesis: A potential bone anabolic treatment. Nat. Med. 16(3), 308-312 (2010). [2]. Abid S, et al. Inhibition of gut- and lung-derived serotonin attenuates pulmonary hypertension in mice. Am J Physiol Lung Cell Mol Physiol. 2012 Sep 15;303(6):L500-8. [3]. Krevvata M, et al. Inhibition of leukemia cell engraftment and disease progression in mice by osteoblasts. Blood. 2014 Oct 30;124(18):2834-46. |
规格 |
1mg 5mg 10mg 25mg |
单位 |
瓶 |